<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hepatocyte transplantation for patients with acute liver failure</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hepatocyte transplantation for patients with acute liver failure</h1>
<div class="graphic"><div class="figure"><div class="ttl">Hepatocyte transplantation for patients with acute liver failure</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="15%"></colgroup><colgroup width="70%"></colgroup> <tbody> <tr> <td class="subtitle1">Diagnosis, [reference]</td> <td class="subtitle1">Age</td> <td class="subtitle1">Procedure and outcome</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Acetaminophen</td> </tr> <tr> <td class="centered">[1]</td> <td>16 years</td> <td>Intraportal <span class="nowrap_whitespace">(4×10<sup>7</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span>, encephalopathy grade 4 unchanged. Died on day 2.</td> </tr> <tr> <td class="centered">[7]</td> <td>26 years</td> <td>Intrasplenic <span class="nowrap_whitespace">(1.2×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved, day 2 OLT, full recovery.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Isoniazid</td> </tr> <tr> <td class="centered">[1]</td> <td>12 years</td> <td>Intraportal <span class="nowrap_whitespace">(1×10<sup>8</sup></span> cells × 3), NH<sub>3</sub> <span class="arrow">↓</span>, encephalopathy grade 4 unchanged. Died on day 7.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Phenytoin</td> </tr> <tr> <td class="centered">[1]</td> <td>10 years</td> <td>Intraportal <span class="nowrap_whitespace">(2.8×10<sup>9</sup></span> cells × 3), NH<sub>3</sub> <span class="arrow">↓</span>, encephalopathy grade 4 unchanged. Died of viral meningitis on day 7.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Dilantin</td> </tr> <tr> <td class="centered">[2]</td> <td>13 years</td> <td>Intraportal <span class="nowrap_whitespace">(1×10<sup>9</sup></span> cells), encephalopathy grade 4 unchanged. Died on day 4.</td> </tr> <tr> <td class="centered">[7]</td> <td>27 years</td> <td>Intrasplenic <span class="nowrap_whitespace">(2.8×10<sup>7</sup>),</span> NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved, day 10 OLT, full recovery.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Tegretol</td> </tr> <tr> <td class="centered">[3]</td> <td>14.8 years</td> <td>Intraportal <span class="nowrap_whitespace">(2.5×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span>, encephalopathy grade 4 improved. OLT on day 1. Full recovery, 6 year follow-up.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Idiopathic</td> </tr> <tr> <td class="centered">[1]</td> <td>3 years</td> <td>Intraportal <span class="nowrap_whitespace">(4×10<sup>9</sup></span> cells × 9). NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy improved. Full recovery.</td> </tr> <tr> <td class="centered">[1]</td> <td>5 years</td> <td>Intraportal <span class="nowrap_whitespace">(2×10<sup>9</sup></span> cells × 7). NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved. OLT on day 4. Full recovery.</td> </tr> <tr> <td class="centered">[4]</td> <td>3.5 months</td> <td>Intraportal <span class="nowrap_whitespace">(1.8×10<sup>8</sup></span> cells). Encephalopathy unchanged. OLT on day 1. Full recovery.</td> </tr> <tr> <td class="centered">[5]</td> <td>8 years</td> <td>Intraperitoneal <span class="nowrap_whitespace">(6×10<sup>7</sup></span> fetal liver cells/kg body weight). Encephalopathy grade 3 improved, full recovery.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Halothane</td> </tr> <tr> <td class="centered">[2]</td> <td>43 years</td> <td>Encephalopathy grade 4 improved. Died on day 35 from sepsis.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Polysubstance use disorder</td> </tr> <tr> <td class="centered">[6]</td> <td>32 years</td> <td>Intrasplenic <span class="nowrap_whitespace">(1.3×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved to grade 2. Died on day 14 from sepsis.</td> </tr> <tr> <td class="centered">[6]</td> <td>35 years</td> <td>Intrasplenic <span class="nowrap_whitespace">(1×10<sup>10</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved. Died on day 20 from sepsis.</td> </tr> <tr> <td class="centered">[3]</td> <td>21 years</td> <td>Intrasplenic <span class="nowrap_whitespace">(9×10<sup>8</sup></span> cells × 2 and <span class="nowrap_whitespace">2.5×10<sup>7</sup> × 1),</span> encephalopathy grade 4 unchanged, day 1 brain death.</td> </tr> <tr> <td class="centered">[3]</td> <td>35 years</td> <td>After OLT, intraportal <span class="nowrap_whitespace">(5.4×10<sup>9</sup> cells),</span> NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved. Died on day 18 from sepsis.</td> </tr> <tr> <td class="centered">[3]</td> <td>35 years</td> <td>Intraportal, <span class="nowrap_whitespace">(3.7×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved, full recovery with more than 1 year follow-up.</td> </tr> <tr> <td class="centered">[3]</td> <td>51 years</td> <td>Intraportal <span class="nowrap_whitespace">(3.9×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved, died of mesenteric thrombosis on day 3.</td> </tr> <tr> <td class="centered">[6]</td> <td>32 years</td> <td>Intraperitoneal <span class="nowrap_whitespace">(6×10<sup>7</sup></span> fetal hep/kg), encephalopathy grade 4 unchanged. Died after 30 hours.</td> </tr> <tr> <td class="centered">[6]</td> <td>29 years</td> <td>Intraperitoneal (6×10<sup>7</sup> fetal hep/kg), encephalopathy grade 4 unchanged. Died after 37 hours.</td> </tr> <tr> <td class="centered">[6]</td> <td>20 years</td> <td>Intraperitoneal <span class="nowrap_whitespace">(6×10<sup>7</sup></span> fetal hep/kg), encephalopathy grade 4 unchanged, Died after 48 hours.</td> </tr> <tr> <td class="centered">[6]</td> <td>20 years</td> <td>Intraperitoneal <span class="nowrap_whitespace">(6×10<sup>7</sup></span> fetal hep/kg), encephalopathy grade 4 improved, full recovery.</td> </tr> <tr> <td class="centered">[6]</td> <td>24 years</td> <td>Intraperitoneal <span class="nowrap_whitespace">(6×10<sup>7</sup></span> fetal hep/kg), encephalopathy grade 3 improved, full recovery.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Chloroform, alcohol</td> </tr> <tr> <td class="centered">[6]</td> <td>55 years</td> <td>Intrasplenic <span class="nowrap_whitespace">(3.9×10<sup>10</sup></span> cells), encephalopathy grade 4 unchanged, multisystem organ failure at 6 hours.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Neonatal hemochromatosis</td> </tr> <tr> <td class="centered">[10]</td> <td>3 days</td> <td>Intraperitoneal injection of <span class="nowrap_whitespace">(2.5×10<sup>7</sup>/kg)</span> alginate encapsulated hepatocytes. INR normalized by day 10. Patient survived without liver transplantation.</td> </tr> <tr> <td class="centered">[10]</td> <td>1 day</td> <td>Two intraperitoneal injections <span class="nowrap_whitespace">(2.4×10<sup>7</sup>/kg</span> and <span class="nowrap_whitespace">3×10<sup>7</sup>/kg)</span> alginate encapsulated hepatocytes. INR continued to be abnormal. Patient received liver transplantation on day 28.</td> </tr> <tr> <td class="centered">[10]</td> <td>14 days</td> <td>Intraperitoneal injection of <span class="nowrap_whitespace">(2×10<sup>7</sup>/kg)</span> alginate encapsulated hepatocytes. INR normalized by day 35. Patient survived without liver transplantation.</td> </tr> <tr> <td class="centered">[10]</td> <td>41 days</td> <td>Two intraperitoneal injections <span class="nowrap_whitespace">(3×10<sup>7</sup>/kg</span> and <span class="nowrap_whitespace">2.3×10<sup>7</sup>/kg)</span> alginate encapsulated hepatocytes. INR continued to be abnormal. Patient received liver transplantation on day 44.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Etiology unknown</td> </tr> <tr> <td class="centered">[8]</td> <td>23 years</td> <td>Intrasplenic, <span class="nowrap_whitespace">(2.86×10<sup>8</sup></span> and <span class="nowrap_whitespace">1.52×10<sup>8</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span>, and encephalopathy grade 3 improved, OLT on day 5, multisystem organ failure on day 13.</td> </tr> <tr> <td class="centered">[10]</td> <td>6 years</td> <td>Intraperitoneal injection of <span class="nowrap_whitespace">(1.5×10<sup>7</sup>/kg)</span> alginate encapsulated hepatocytes. INR remained persistently abnormal until patient received liver transplantation on day 8.</td> </tr> <tr> <td class="centered">[10]</td> <td>8 days</td> <td>Intraperitoneal injection of <span class="nowrap_whitespace">(2.6×10<sup>7</sup>/kg)</span> alginate encapsulated hepatocytes. INR increased on day 1. Patient died on day 1.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Reyes syndrome</td> </tr> <tr> <td class="centered">[3]</td> <td>48 years</td> <td>Intraportal, <span class="nowrap_whitespace">(7.5×10<sup>8</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span>, encephalopathy grade 4 unchanged, brain death on day 1.</td> </tr> <tr> <td class="subtitle2_left" colspan="3"><em>Amanita phalloides</em></td> </tr> <tr> <td class="centered">[8]</td> <td>64 years</td> <td>Intraportal, <span class="nowrap_whitespace">(4.9×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved, full recovery, off immunosuppression 12 weeks.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Post-surgical trisegmentectomy</td> </tr> <tr> <td class="centered">[2]</td> <td>69 years</td> <td>Intrasplenic, <span class="nowrap_whitespace">(3.6×10<sup>8</sup></span> cells and <span class="nowrap_whitespace">1.7×10<sup>8</sup></span> cells), encephalopathy grade 4 unchanged, died on day 2.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Herpes II</td> </tr> <tr> <td class="centered">[6]</td> <td>29 years</td> <td>Intraportal + intrasplenic <span class="nowrap_whitespace">(1×10<sup>10</sup></span> cells), encephalopathy grade 4 unchanged, O<sub>2</sub> <span class="arrow">↓</span>. Died after 18 hours.</td> </tr> <tr> <td class="centered">[4]</td> <td>37 years</td> <td>Intrasplenic, <span class="nowrap_whitespace">(1.2×10<sup>8</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved. Died on day 5 from sepsis.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">HBV</td> </tr> <tr> <td class="centered">[6]</td> <td>65 years</td> <td>Intraportal + intrasplenic, <span class="nowrap_whitespace">(3×10<sup>10</sup></span> cells), encephalopathy grade 3 improved, NH<sub>3</sub> <span class="arrow">↓</span> &amp; O<sub>2</sub> <span class="arrow">↓</span>, multisystem organ failure on day 52.</td> </tr> <tr> <td class="centered">[2]</td> <td>28 years</td> <td>Intrasplenic, <span class="nowrap_whitespace">(1.69×10<sup>8</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 4 improved, OLT day 3, full recovery.</td> </tr> <tr> <td class="centered">[2]</td> <td>43 years</td> <td>Intraportally, <span class="nowrap_whitespace">(2.43×10<sup>8</sup></span> cells × 3), encephalopathy 4, OLT on day 1, full recovery.</td> </tr> <tr> <td class="centered">[5]</td> <td>40 years</td> <td>Intraperitoneal, <span class="nowrap_whitespace">(6×10<sup>7</sup></span> cells/kg body weight), encephalopathy grade 4 unchanged. Died after 13 hours.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">HBV + cocaine</td> </tr> <tr> <td class="centered">[9]</td> <td>37 years</td> <td>Intrasplenic, <span class="nowrap_whitespace">(8.8×10<sup>8</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 2 improved, full recovery with 7-year follow-up.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">HBV + lymphoma</td> </tr> <tr> <td class="centered">[3]</td> <td>54 years</td> <td>Intraportal, <span class="nowrap_whitespace">(6.6×10<sup>9</sup></span> cells), NH<sub>3</sub> <span class="arrow">↓</span> and encephalopathy grade 2 improved, multisystem organ death day 7.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">HSV 1</td> </tr> <tr> <td class="centered">[10]</td> <td>15 days</td> <td>Alginate encapsulated hepatocytes <span class="nowrap_whitespace">(2×10<sup>7</sup>/kg)</span> were transplanted by intraperitoneal injection. INR was normalized by day 10. Patient survived without liver transplant.</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Adenovirus</td> </tr> <tr> <td class="centered">[10]</td> <td>17 months</td> <td>Alginate encapsulated hepatocytes <span class="nowrap_whitespace">(2×10<sup>7</sup>/kg)</span> were transplanted by intraperitoneal injection. INR was normalized by day 6. Patient survived without liver transplant.</td> </tr> </tbody></table></div><div class="graphic_footnotes">NH<sub>3</sub>: ammonia; OLT: orthotopic liver transplantation; INR: international normalized ratio; HBV: hepatitis B virus; HSV: herpes simplex virus.</div><div class="graphic_reference">References:
<ol>
<li>Soriano HE, Wood RP, Kang DC, et al. Hepatocellular transplantation HCT) in children with fulminant liver failure. Hepatology 1997; 30:239A.</li>
<li>Strom SC, Roy-Chowdhury J, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999; 19:39.</li>
<li>Fisher RA, Strom SC. Human hepatocyte Transplantation: Worldwide results. Transplantation 2006; 82:441.</li>
<li>Sterling RK, Fisher RA. Liver Transplantation: Living Donor, Hepatocyte, and Xenotransplantation. In: Current Future Treatment Therapies for Liver Disease. Clinics in Liver Disease. Gish R, ed. Philadelphia: WB Saunders, 2001.</li>
<li>Habibullah CM, Syed IH, Qamar A, Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994; 58:951.</li>
<li>Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transp 2000; 6:32.</li>
<li>Fisher RA, Strom SC. Human Hepatocyte Transplantation: Biology and Therapy. In the Hepatocyte Review. Berry MN, Edwards AM, eds. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2000.</li>
<li>Ott M, Barthold M, Alexandrova K, et al. Clinical applications of human hepatocytes isolated under CGMP conditions. 40th annual meeting of the European Association for the study of the liver. 2005: Ab 716.</li>
<li>Fisher RA, Bu D, Thompson M, et al. Defining hepatocellular chimerism of a liver failure patient bridged with hepatocyte infusion. Transplantation 2000; 69:303.</li>
<li>Dhawan A, Chaijitraruch N, Fitzpatrick E, et al. Alginate miroencapsulated human hepatocytes for the treatment of acute liver failure in children. J Hepatology 2020; 72:877.</li>
</ol></div><div id="graphicVersion">Graphic 69654 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
